Pandemic: Upcoming Site Challenges and the Impact on Clinical Supply Planning

COVID-19 has created a huge impact in planning, forecasting and budgeting for sponsors, not just for the future, but also for current studies. It has also severely impacted investigational sites. Considering that the site network remains critical to the success of studies, Ryoma (Ray) Collia and Dr Vivienne van de Walle will speak about various challenges and situations faced by investigational sites due to COVID-19, their potential consequences and ways Sponsors can be helped to mitigate and manage the risks of potential or current changes in plans within the supply chain and partner network.

Site challenges and the impact on Clinical Supply Planning

Ryoma (Ray) Collia, Vice President Sales at S-CLINICA and Dr Vivienne van de Walle, Director at PT&R co-hosted a session “Site challenges and the impact on Clinical Supply Planning” on Thursday, March 25 at Clinical Trial Supply Europe virtual event.

S-CLINICA welcomes Ryoma Collia, Vice President Sales

Ryoma Collia

S-Clinica is pleased to announce the appointment of Ryoma Collia as Vice President Sales. With a solid background in sales for over thirty-three years, Ryoma brings over ten years of experience in Life Sciences, seven of which has been within Clinical Trials.

Clinical Trials Europe 2020 Virtual Conference

S-CLINICA Executive Director Irena Seredina and the Vice President of Strategic Alliances Matthew Konneh participated in the Roundtable Forum in December 2020 for Clinical Trial professionals.

Clinical Trials Europe 2020 – virtual conference

Outsourcing in Clinical Trials Europe event served as a bridge between clinical trial teams representing sponsors of all sizes and vendors. With the patient centric approach in mind both sponsors and vendors worked together to manage creative, technical and regulatory demands making sure that patients are safe at all stages of a clinical trial.

S-CLINICA participates at the Clinical Trial Supply online forum

Industry professionals discussed many interesting during two days of the event. Of the most productive and trendy discussion threads there were those on: how to lead effective end-to-end clinical trial management and ensure that IRT execution is fit for purpose, discussions on clinical trial data transfer & integrations, blockchain and AI for improvement of global supply efficiency as well as discussions on clinical trials of the future.

Software of clairvoyance, structure and reliability

Nowadays clinical trials require advanced software systems to get them up and running efficiently. The capability of those systems are not only about organisation, but is about foreseeing potential issues as well as troubleshooting them. Irena Seredina and Muriel Comblain, executive director and head of operations at S-Clinica respectively, discuss how their company’s clinical trial management system is helping clients around the world anticipate and mitigate risks, while continuing to keep costs under control.

SCOPE Summit 2020

On February 18-21 S-Clinica participates in SCOPE Summit 2020 for Clinical OPS Executives that takes place in Orlando, USA.